ישראל - עברית - Ministry of Health

neopharm ltd, israel - levoketoconazole - טבליה - levoketoconazole 150 mg

ישראל - עברית - Ministry of Health

bayer israel ltd - chlorhexidine dihydrochloride; dexpanthenol - קרם - dexpanthenol 5 %; chlorhexidine dihydrochloride 0.5 % - chlorhexidine, combinations - chlorhexidine, combinations - antiseptic healing treatment of wounds of any kind with an infection risk : such as slight skin irritations, wounds, cuts, burns and skin inflammation.

ישראל - עברית - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole

ישראל - עברית - Ministry of Health

bayer israel ltd - clotrimazole - קרם - clotrimazole 1 %w/w - clotrimazole

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 1 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 2 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 5 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - elagolix as sodium - טבליות מצופות פילם - elagolix as sodium 150 mg - elagolix

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - elagolix as sodium - טבליות מצופות פילם - elagolix as sodium 200 mg - elagolix

ישראל - עברית - Ministry of Health

takeda israel ltd - maribavir - טבליות מצופות פילם - maribavir 200 mg - maribavir